Accession Number:

AD1116532

Title:

Clinical Trial of a Comprehensive Treatment for High-Functioning Children with ASD

Descriptive Note:

Technical Report,01 Jul 2015,30 Jun 2020

Corporate Author:

Canisius College Buffalo United States

Personal Author(s):

Report Date:

2020-09-01

Pagination or Media Count:

263.0

Abstract:

This RCT tested the efficacy of an outpatient psychosocial treatment for children with ASD without intellectual disability ID.Eighty-eight children ages 7-12 yrs were randomly assigned to the treatment or control condition. The 18-week cognitive behavioral treatment two 90-min sessions per week included small-group instruction and therapeutic activities targeting socialsocial-communication skills, face-emotion recognition, nonliteral language skills, and interest expansion. A behavioral system was used to increase skills development and reduce ASD symptoms. Efficacy was assessed immediately following the18-week treatment posttest and 4-6 weeks post-treatment. Measures included parent ratings of the childrens socialsocial communication skills, ASD symptoms, broad social skills, and behavior symptoms, child tests of social-cognitive skills emotion recognition and nonliteral language, and behavioral observations. Results revealed significant effects favoring the treatment group at posttest on the primary measures of ASD symptoms and socialsocial-communication skills, and secondary measures of nonliteral language skills, broad social skills, and behavior symptoms measures of emotion-recognition skills and social behaviors during structured game sessions were non-significant. The significant treatment effects found at posttest were all maintained at follow-up.

Subject Categories:

  • Linguistics
  • Psychology
  • Personnel Management and Labor Relations
  • Medicine and Medical Research
  • Linguistics
  • Psychology
  • Personnel Management and Labor Relations
  • Medicine and Medical Research
  • Linguistics
  • Psychology
  • Personnel Management and Labor Relations
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE